leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Fibrofolliculoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Inflammation of large intestine
|
phenotype |
Digestive System Diseases
|
Disease or Syndrome
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Li-Fraumeni Syndrome 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
11
|
0.700 |
None |
1.000 |
0 |
11
|
2001 |
2018 |
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
7
|
0.100 |
None |
|
0 |
7
|
|
|
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
|
disease |
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Thymus Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Li-Fraumeni Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2
|
157
|
0.700 |
None |
0.963 |
9 |
4
|
1999 |
2017 |
Hematochezia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
2
|
2
|
0.100 |
None |
|
0 |
1
|
|
|
Neuroendocrine Tumors
|
group |
Neoplasms
|
Neoplastic Process
|
2
|
4
|
0.100 |
None |
|
0 |
1
|
|
|
Parathyroid Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2
|
4
|
0.100 |
None |
|
0 |
1
|
|
|
Type 1 Papillary Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2
|
3
|
0.100 |
None |
|
0 |
2
|
|
|
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2
|
3
|
0.200 |
None |
0.750 |
0 |
1
|
2003 |
2019 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3
|
5
|
0.160 |
None |
0.833 |
0 |
1
|
2000 |
2018 |
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
3
|
8
|
0.100 |
None |
|
0 |
1
|
|
|
Diffuse Intrinsic Pontine Glioma
|
disease |
|
Neoplastic Process
|
3
|
3
|
0.100 |
None |
|
0 |
1
|
|
|
Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
4
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
4
|
20
|
0.740 |
None |
1.000 |
0 |
9
|
2002 |
2019 |
Thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
4
|
4
|
0.130 |
None |
1.000 |
0 |
1
|
2015 |
2019 |
PROSTATE CANCER, SUSCEPTIBILITY TO
|
phenotype |
|
Finding
|
4
|
6
|
0.100 |
None |
|
0 |
2
|
|
|
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
5
|
48
|
0.100 |
None |
1.000 |
22 |
1
|
1999 |
2014 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
5
|
26
|
0.100 |
None |
|
0 |
1
|
|
|
Polyp of large intestine
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5
|
6
|
0.100 |
None |
|
0 |
1
|
|
|
increased risk of pancreatic cancer
|
phenotype |
Neoplasms
|
Finding
|
5
|
6
|
0.100 |
None |
|
0 |
2
|
|
|